NASA Logo

NTRS

NTRS - NASA Technical Reports Server

Back to Results
Effects of the 8 psia / 32% O2 Atmosphere on the Human in the Spaceflight EnvironmentExtravehicular activity (EVA) is at the core of a manned space exploration program. There are elements of exploration that may be safely and effectively performed by robots, but there are critical elements of exploration that will require the trained, assertive, and reasoning mind of a human crewmember. To effectively use these skills, NASA needs a safe, effective, and efficient EVA component integrated into the human exploration program. The EVA preparation time should be minimized and the suit pressure should be low to accommodate EVA tasks without undue fatigue, physical discomfort, or suit-related trauma. Commissioned in 2005, the Exploration Atmospheres Working Group (EAWG) had the primary goal of recommending to NASA an internal environment that allowed efficient and repetitive EVAs for missions that were to be enabled by the former Constellation Program. At the conclusion of the EAWG meeting, the 8.0 psia and 32% oxygen (O2) environment were recommended for EVA intensive phases of missions. As a result of selecting this internal environment, NASA gains the capability for efficient EVA with low risk of decompression sickness (DCS), but not without incurring additional negative stimulus of hypobaric hypoxia to the already physiologically challenging spaceflight environment. This paper provides a literature review of the human health and performance risks associated with the 8 psia/32% O2 environment. Of most concern are the potential effects on the central nervous system including increased intracranial pressure, visual impairment, sensorimotor dysfunction, and oxidative damage. Other areas of focus include validation of the DCS mitigation strategy, incidence and treatment of acute mountain sickness (AMS), development of new exercise countermeasures protocols, effective food preparation at 8 psia, assurance of quality sleep, and prevention of suit-induced injury. As a first effort, the trade space originally considered in the EAWG was re-evaluated looking for ways to decrease the hypoxic dose by further enriching the O2% or increasing the pressure. After discussion with the NASA engineering and materials community, it was determined that the O2 could be enriched from 32% to 34% and the pressure increased from 8.0 to 8.2 psia without significant penalty. These two small changes increase alveolar O2 pressure by 11 mmHg, which is expected to significantly benefit crewmembers. The 8.2/34 environment (inspired O2 pressure = 128 mmHg) is also physiologically equivalent to the staged decompression atmosphere of 10.2 psia / 26.5% O2 (inspired O2 pressure = 127 mmHg) used on 34 different shuttle missions for approximately a week each flight. Once decided, the proposed internal environment, if different than current experience, should be evaluated through appropriately simulated research studies. In many cases, the human physiologic concerns can be investigated effectively through integrated multi-discipline ground-based studies. Although missions proposing to use an 8.2/34 environment are still years away, it is recommended that these studies begin early enough to ensure that the correct decisions pertaining to vehicle design, mission operational concepts, and human health countermeasures are appropriately informed.
Document ID
20130013505
Acquisition Source
Johnson Space Center
Document Type
Technical Memorandum (TM)
Authors
Norcross, Jason
(Wyle Integrated Science and Engineering Group Houston, TX, United States)
Norsk, Peter
(Universities Space Research Association (USRA) Houston, TX, United States)
Law, Jennifer
(NASA Johnson Space Center Houston, TX, United States)
Arias, Diana
(Wyle Integrated Science and Engineering Group Houston, TX, United States)
Conkin, Johnny
(Universities Space Research Association (USRA) Houston, TX, United States)
Perchonok, Michele
(NASA Johnson Space Center Houston, TX, United States)
Menon, Anil
(Wyle Labs., Inc. Houston, TX, United States)
Huff, Janice ORCID
(Universities Space Research Association (USRA) Houston, TX, United States)
Fogarty, Jennifer
(NASA Johnson Space Center Houston, TX, United States)
Wessel, James H., III
(Wyle Integrated Science and Engineering Group Houston, TX, United States)
Whitmire, Sandra
(Wyle Integrated Science and Engineering Group Houston, TX, United States)
Date Acquired
August 27, 2013
Publication Date
June 1, 2013
Subject Category
Aerospace Medicine
Report/Patent Number
S-1141
JSC-CN-28625
NASA/TM-2013-217377
Distribution Limits
Public
Copyright
Public Use Permitted.
Keywords
Environmental control
Controlled atmospheres
No Preview Available